SAS Output

13-JUL-2020 6:10

GU ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1602-Blad, HG NMIBC, TICE/Tokyo/Prime+Tokyo BCG 1 Y 1 TICE BCG 969 253 107 73 30 9 2 02/24/2017 184 91
        2 Tokyo-172 BCG   253 108 73 32 9 3      
        3 Prime + Tokyo-172 BCG   255 109 75 35 13 3      
            761 324 221 97 31 8      
 
  S1802-Pros, Stg IV, SST +/- Surg/RT to Primary Tum 1 Y 0 Induction SST 1273 215 140 65 34 14 2 09/24/2018 272 128
            215 140 65 34 14 2      
 
    2 Y 1 Standard Systemic Therapy Only 1273 73 55 27 15 3 1 09/24/2018    
        2 SST + Surgery/RT   70 51 26 12 1 0      
            143 106 53 27 4 1      
 
  S1806-Blad, MIBC, ChemoRT +/- Atezolizumab 1 Y 0 Initial Registration 475 84 83 47 26 7 3 06/03/2019 285 126
            84 83 47 26 7 3      
 
    2 Y 1 Chemo + RT 475 39 38 23 11 2 0 06/03/2019    
        2 Chemo + RT + Atezolizumab   36 36 20 11 4 2      
            75 74 43 22 6 2      
 
Yes A031102-GCT, Recur, Std Chemo(TIP) vs HD Chemo(TI-CE) 1 E Total Registrations   6 1 0 0 0 0 11/23/2016 54 37
            6 1 0 0 0 0      
 
  A031702-GU, Mets, Cabozantinib+Nivo+Ipi (ICONIC) 1 E Total Registrations   10 10 4 0 0 0 08/09/2019 201 85
            10 10 4 0 0 0      
 
  A031704-RCC, Met, Ipi+Nivo followed by Nivo+/-Cabo 1 E Total Registrations   20 20 14 5 3 2 10/02/2019 229 106
            20 20 14 5 3 2      
 
    2 E Total Registrations   12 12 12 7 5 0 10/02/2019    
            12 12 12 7 5 0      
 
  A031803-Blad, NMIBC, Gemcitabine + MK-3475 1 E Total Registrations   3 3 3 2 0 0 03/18/2020 37 15
            3 3 3 2 0 0      
 
  EA8143-RCC, HR, Surg +/- Nivolumab (PROSPER) 0 E Total Registrations   114 61 31 12 4 2 09/29/2017 264 146
            114 61 31 12 4 2      
 
    1 E Total Registrations   102 57 28 10 2 1 09/29/2017    
            102 57 28 10 2 1      
 
  EA8171-PROS, newly diagnosed, mpMRI for pre-op stagi 1 E Total Registrations   23 17 2 0 0 0 02/11/2019 83 38
            23 17 2 0 0 0      
 
  NRGGU002-Pros, RT + ADT After RP +/- Adj Docetaxel 1 E Total Registrations   3 0 0 0 0 0 08/24/2017 199 102
            3 0 0 0 0 0      
 
    2 E Total Registrations   3 0 0 0 0 0 08/24/2017    
            3 0 0 0 0 0      
 
  NRGGU005-PROS, intmd risk, IGRT& SBRT vs IGRT& HF-IMRT 1 E Total Registrations   2 1 1 1 0 0 03/19/2019 239 117
            2 1 1 1 0 0      
 
  NRGGU006-PROS, post-RP PSA, SRT +/- ADT w/Apalutamide 1 E Total Registrations   4 2 0 0 0 0 03/22/2019 306 129
            4 2 0 0 0 0      
 
    2 E Total Registrations   4 2 1 0 0 0 03/22/2019    
            4 2 1 0 0 0      
 
No A031501-Bladder, MIBC/Loc Adv, Adjv Pembro vs Obs 0 E Total Registrations   73 28 14 11 6 3 05/03/2018 223 139
            73 28 14 11 6 3      
 
    1 E Total Registrations   67 30 10 6 4 1 05/03/2018    
            67 30 10 6 4 1      
 
  A031701-Bladder, ddGC for MIBC with DDR Tumor Alt 1 E Total Registrations   5 4 3 2 0 0 12/17/2018 141 56
            5 4 3 2 0 0      
 
    2 E Total Registrations   4 3 3 2 2 1 12/17/2018    
            4 3 3 2 2 1      
 
  EA8134-Penile, Local Adv, ILND +/- Chemo or ChemoRT 1 E Total Registrations   6 5 2 1 0 0 04/25/2019    
            6 5 2 1 0 0      
 
  EA8153-Pros, ADT + Abira +/- Cabazitaxel (CHAARTED2) 1 E Total Registrations   24 17 1 1 1 0 08/08/2018 225 91
            24 17 1 1 1 0